| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/16/2009 | DE102005050914B4 Tragbares Gasmessgerät Portable gas detector |
| 04/16/2009 | CA2779595A1 Method for determining the amount of heat stress that has been inflicted on fruit juice |
| 04/16/2009 | CA2704796A1 Systems and methods for automated characterization of genetic heterogeneity in tissue samples |
| 04/16/2009 | CA2702561A1 Portable device for detecting food allergens |
| 04/16/2009 | CA2702549A1 Hand held micro pcr device |
| 04/16/2009 | CA2702470A1 Functional lipid constructs |
| 04/16/2009 | CA2702418A1 Micro chip |
| 04/16/2009 | CA2702366A1 Compositions affecting hyaluronic acid mediated activity |
| 04/16/2009 | CA2702314A1 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors |
| 04/16/2009 | CA2702276A1 Microfluidic platforms for multi-target detection |
| 04/16/2009 | CA2702268A1 Methods for detecting major adverse cardiovascular and cerebrovascular events |
| 04/16/2009 | CA2702212A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 04/16/2009 | CA2702121A1 Measurement of arylesterase enzymatic activity and assessment of genetic polymorphisms located in the pon1 gene as a diagnostic tool in autism-spectrum disorders |
| 04/16/2009 | CA2701971A1 Reduction of wire numbers in a paper scanner power track |
| 04/16/2009 | CA2701794A1 Modular point-of-care devices and uses thereof |
| 04/16/2009 | CA2701715A1 Anionic surfactant detection |
| 04/16/2009 | CA2701571A1 Polypeptide markers for the diagnosis of prostate cancer |
| 04/16/2009 | CA2701459A1 Method and device for detecting degradation in the quality of a brake fluid |
| 04/16/2009 | CA2701067A1 Systems and methods for improving haul road conditions |
| 04/15/2009 | EP2048534A1 Method for the surface treatment of solid substrates |
| 04/15/2009 | EP2048506A1 Postprandial hyperglycemia marker, method for determination thereof, and use thereof |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048504A1 Detecting, localizing, and targeting internal sites in vivo using optical contrast agents |
| 04/15/2009 | EP2048503A1 Assay for monitoring activity of frizzled receptors |
| 04/15/2009 | EP2048502A1 Method of confirming the specimen-detecting activity of microparticles |
| 04/15/2009 | EP2048501A1 Antibody specific to intact human autotaxin, method of screening the same and method and reagent for examining malignant lymphoma by assaying autotaxin |
| 04/15/2009 | EP2048500A1 Method of determining a concentration of analytes of interest in a sample |
| 04/15/2009 | EP2048499A1 Method and apparatus for correcting ambient temperature effect in biosensor |
| 04/15/2009 | EP2048498A1 Analysis method and analysis apparatus |
| 04/15/2009 | EP2048245A1 A totally-enclosed device for quick detection of target nucleic acid amplification product |
| 04/15/2009 | EP2048241A1 Molecular markers for cancer prognosis |
| 04/15/2009 | EP2048239A1 Glyceroglycolipid antigen of mycoplasma pneumoniae |
| 04/15/2009 | EP2048234A1 Chromatographic method for purification of albumin |
| 04/15/2009 | EP2048228A2 Human liver progenitors |
| 04/15/2009 | EP2048223A1 Cell chip |
| 04/15/2009 | EP2048163A1 Antihuman alpha- 9 integrin antibody and use of the same |
| 04/15/2009 | EP2048162A1 Novel monoclonal antibody and use of the same |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP2048140A1 Deuterated chemiluminescent 1,2-dioxetanes |
| 04/15/2009 | EP2047910A2 Microfluidic devices |
| 04/15/2009 | EP2047909A2 Reaction cassette for measuring the concentration of glycated hemoglobin and measuring method thereof |
| 04/15/2009 | EP2047860A1 Phamaceutical compositons comprosing actinomycete glycerol acyl derivatives antigens, their process of extractin, and their use against tuberculosis. |
| 04/15/2009 | EP2047444A2 System and method for high-sensitivity sensor |
| 04/15/2009 | EP2047408A2 Method for detecting fluorescent signals in a biological sample |
| 04/15/2009 | EP2047281A2 Method for the determination of phospholipids in amniotic fluid samples |
| 04/15/2009 | EP2047280A1 Standard/reference/control for blood coagulation testing |
| 04/15/2009 | EP2047279A1 A reagent for digestion of hemoglobin |
| 04/15/2009 | EP2047278A2 Prediction and prophylactic treatment of type 1 diabetes |
| 04/15/2009 | EP2047277A2 Methods and tools for the therapy of neurodegenerative pathologies |
| 04/15/2009 | EP2047276A2 Method for the prediction of vascular events and the diagnosis of acute coronary syndrome |
| 04/15/2009 | EP2047275A2 Means and methods for assessing the risk of cardiac interventions based on gdf-15 |
| 04/15/2009 | EP2047274A2 Secretogranin and vgf peptide biomarkers and uses thereof |
| 04/15/2009 | EP2047273A1 Method and reagent mixture to make amino acids and peptides visible |
| 04/15/2009 | EP2047272A1 Electrochemical determination system of glycated proteins |
| 04/15/2009 | EP2047271A1 Method for establishing the sensitivity of tumours to capecitabin and test kit |
| 04/15/2009 | EP2047270A2 Stabilizing agents and capture ligands for use in assays measuring analyte concentrations |
| 04/15/2009 | EP2047269A1 Measurement of complement activation products on antigen arrays |
| 04/15/2009 | EP2047268A1 Indicator system for determining analyte concentration |
| 04/15/2009 | EP2047267A1 Biosensor |
| 04/15/2009 | EP2047266A1 Formation of bilayers of amphipathic molecules |
| 04/15/2009 | EP2047265A2 Method for influencing living cells through cell-surface interaction |
| 04/15/2009 | EP2047264A2 Method of measurement of cellular hemoglobin |
| 04/15/2009 | EP2047263A2 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes |
| 04/15/2009 | EP2047262A2 Methods for making cancer prognoses based on the subcellular localization of biomarkers |
| 04/15/2009 | EP2047261A1 Immunochromatographic strip for use in immunoassay and kit comprising the same |
| 04/15/2009 | EP2047260A2 Enabling methods to identify allosteric modulators of receptor activity |
| 04/15/2009 | EP2047259A1 Biosensor comprising interdigitated electrode sensor units |
| 04/15/2009 | EP2047258A1 Blood cell separation |
| 04/15/2009 | EP2047257A1 Novel cellular glycan compositions |
| 04/15/2009 | EP2047256A1 A method for the in vitro screening of anti-cancer compounds that inhibits sk3 activity, and said anti-cancer compounds |
| 04/15/2009 | EP2047255A1 Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents |
| 04/15/2009 | EP2047254A2 Method relating to sweetness enhancement |
| 04/15/2009 | EP2047253A1 Electrochemical detection of magnetic particle mobility |
| 04/15/2009 | EP2047252A1 Structure of the insulin receptor ectodomain |
| 04/15/2009 | EP2047251A2 Image processing method for a microscope system |
| 04/15/2009 | EP2047250A2 Photo-acoustic detection device and method |
| 04/15/2009 | EP2047249A2 Device for recording measurement data |
| 04/15/2009 | EP2047248A2 Method and device for determining the fat content of pieces of meat in their entirety |
| 04/15/2009 | EP2047247A2 Method and device for determining the quality of plant products |
| 04/15/2009 | EP2047246A2 Methods and kits for measurement of lymphocyte function |
| 04/15/2009 | EP2047238A1 Radiation detectors using evanescent field excitation |
| 04/15/2009 | EP2047233A1 Activated mercury collector and method for the selective determination of mercury species |
| 04/15/2009 | EP2046977A1 Use of spla2 activity for the diagnosis of a cardiovascular event |
| 04/15/2009 | EP2046975A2 Modulators of hsd17b7 in the treatment of acne or of hyperseborrhoea |
| 04/15/2009 | EP2046973A2 For the identification, assessment, and treatment of patients with cancer therapy |
| 04/15/2009 | EP2046972A2 Method of applying an elongated molecule to a surface |
| 04/15/2009 | EP2046971A2 Quantifiable internal reference standards for immunohistochemistry and uses thereof |
| 04/15/2009 | EP2046965A2 Knockout mice for different genes and their use for gene characterization |
| 04/15/2009 | EP2046950A2 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 04/15/2009 | EP2046895A2 Asymmetric fluoro-substituted polymethine dyes |
| 04/15/2009 | EP2046894A2 Near infrared fluorophore for the selective labelling of membranes in cells |
| 04/15/2009 | EP2046829A2 Model taste cells and methods of use for identifying modulators of taste sensation |
| 04/15/2009 | EP2046828A2 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 04/15/2009 | EP2046823A1 Post-translationally modified neurotrophins |
| 04/15/2009 | EP2046818A2 Method of selective protein enrichment and associated applications |
| 04/15/2009 | EP2046814A2 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
| 04/15/2009 | EP2046807A2 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
| 04/15/2009 | EP2046381A1 Cancerous disease modifying antibodies |
| 04/15/2009 | EP2005174A4 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 04/15/2009 | EP1948819B1 Diamine oxidase determination |